Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules

被引：58

作者：

Meier, C.

Balzarini, J.

机构：

[1] Univ Hamburg, Inst Organ Chem, D-20146 Hamburg, Germany

[2] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium

来源：

ANTIVIRAL RESEARCH | 2006年 / 71卷 / 2-3期

关键词：

nucleoside analogs; antiviral agent; cycloSal-pronucleotides; carbohydrate drugs;

D O I：

10.1016/j.antiviral.2006.04.011

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Pronucleotides represent a promising tool to improve the biological activity of nucleoside analogs in antiviral and cancer chemotherapy. The cycloSal-approach is one of several conceptually different pronucleotide systems. This approach can be applied to various nucleoside analogs. A salicyl alcohol as a cyclic bifunctional masking unit is used, and shown to afford a chemically driven release of the particular nucleotide from the lipophilic phosphate triester precursor molecule. A conceptual extension of the cycloSal-approach results in the design of "lock-in"-cycloSal-derivatives. The cycloSal-approach is not restricted to the delivery of bioactive nucleotides but also useful for the intracellular delivery of hexose-1-phosphates. (c) 2006 Elsevier B.V. All rights reserved.

引用

收藏

页码：282 / 292

页数：11

相关论文

共 38 条

[11]

Ducho Christian, 2002, Antivir Chem Chemother, V13, P129

[12] Effects of cycloSal-d4TMP derivatives in H9 cells with induced AZT resistance phenotype [J].

Gröschel, B ;

Meier, C ;

Zehner, R ;

Cinatl, J ;

Doerr, HW ;

Cinatl, J .

NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (4-5) :933-936

[13] FAMILIAL PSYCHOMOTOR RETARDATION WITH MARKEDLY FLUCTUATING SERUM PROLACTIN, FSH AND GH LEVELS, PARTIAL TBG-DEFICIENCY, INCREASED SERUM ARYLSULFATASE-A AND INCREASED CSF PROTEIN - NEW SYNDROME [J].

JAEKEN, J ;

VANDERSCHUERENLODEWEYCKX, M ;

CASAER, P ;

SNOECK, L ;

CORBEEL, L ;

EGGERMONT, E ;

EECKELS, R .

PEDIATRIC RESEARCH, 1980, 14 (02) :179-179

[14] Synthesis and properties of fluorescent cycloSal nucleotides based on the pyrimidine nucleoside m5K and its 2′,3′-dideoxy analog dM5K [J].

Jessen, HJ ;

Fendrich, W ;

Meier, C .

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2006, 2006 (04) :924-931

[15] Evidence for cyclophosphate formation during hydrolysis of 3-methyl-cycloSal-PCVMP [J].

Lomp, A ;

Meier, C ;

Herderich, M ;

Wutzler, P .

NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (4-5) :943-944

[16] Cyclo-saligenyl-5-fluoro-2'-deoxyuridinemonophosphate (cycloSal-FdUMP) - A new prodrug approach for FdUMP [J].

Lorey, M ;

Meier, C ;

DeClercq, E ;

Balzarini, J .

NUCLEOSIDES & NUCLEOTIDES, 1997, 16 (7-9) :1307-1310

[17] Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy [J].

Mazzon, C ;

Rampazzo, C ;

Scaini, MC ;

Gallinaro, L ;

Karlsson, A ;

Meier, C ;

Balzarini, J ;

Reichard, P ;

Bianchi, V .

BIOCHEMICAL PHARMACOLOGY, 2003, 66 (03) :471-479

[18] Inhibitory effect of cycloSaligenyl-nucleoside monophosphates (cycloSal-NMP) of acyclic nucleoside analogues on HSV-1 and EBV [J].

Meerbach, A ;

Klöcking, R ;

Meier, C ;

Lomp, A ;

Helbig, B ;

Wutzler, P .

ANTIVIRAL RESEARCH, 2000, 45 (01) :69-77

[19] cycloSal-pronucleotides of 2′,3′-dideoxyadenosine and 2′,3′-dideoxy-2′,3′-didehydroadenosine:: Synthesis and antiviral evaluation of a highly efficient nucleotide delivery system [J].

Meier, C ;

Knispel, T ;

De Clercq, E ;

Balzarini, J .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (09) :1604-1614

[20] Second-generation cycloSal-d4TMP pronucleotides bearing esterase-cleavable sites -: the "trapping" concept [J].

Meier, C ;

Ducho, C ;

Jessen, H ;

Vukadinovic-Tenter, D ;

Balzarini, J .

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2006, 2006 (01) :197-206

← 1 2 3 4 →